1. Catalogs
  2. Cutera
  3. AviClear product brochure

AviClear product brochure

AviClear product brochure

AviClear product brochure

Product catalog summary
Introduction
AviClear is the first FDA-cleared laser designed for the long-term treatment of mild, moderate, and severe inflammatory acne. It utilizes a 1726 nm wavelength to target sebocytes, reducing sebum production without harming the epidermis.

Market Demand
The U.S. acne treatment market is projected to reach $7.2 billion by 2030. Currently, 48% of patients are dissatisfied with their acne treatments. AviClear addresses this demand by offering a safe solution for all skin types and tones, suitable for both adolescents and adults.

Treatment Process
AviClear involves a series of quick, 30-minute sessions that provide long-term results. The treatment is supported by clinical studies showing significant improvement in acne severity over time.

Clinical Results
A pivotal study involving 104 patients demonstrated substantial improvement in acne conditions, with a 79% reduction in inflammatory lesions after 12 months. The treatment success rate, defined as 50% or greater improvement, reached 92% at 12 months.

Technology and Safety
AviClear features AviCool technology, combining sapphire contact cooling and smart sensors for a comfortable treatment experience. The laser selectively targets sebaceous glands, minimizing damage to surrounding tissues.

Technical Specifications
  • Wavelength: 1726 nm
  • Maximum Output Power: 100 W
  • Maximum Fluence: Up to 30 J/cm²
  • Spot Size: 3.0 mm
  • Cooling Window Temperature: 0°C to 5°C
  • Console Dimensions: 24.5 x 19 x 38 in.
  • Console Weight: 125 lbs.


Safety and Precautions
AviClear is contraindicated for pregnant patients and those undergoing skin cancer treatment. Potential side effects include discomfort, erythema, and transient acne flare-ups. Specific precautions are advised for patients with certain medical histories or conditions.

Conclusion
Developed by Cutera, a leader in dermatology and aesthetics devices, AviClear represents a significant advancement in acne treatment technology, offering a promising solution for patients seeking effective and long-lasting results.
See more

Catalog excerpts

AviClear product brochure-2

The Future of Acne Treatment AviClear is the first FDA-cleared laser for the long-term treatment of mild, moderate, and severe inflammatory acne. AviClear uses a 1726 nm wavelength to selectively deliver energy, damaging the sebocytes and suppress sebum production without compromising the epidermis. Safe for all skin types and tones in both adolescents and adults1 A series of quick, 30-minute treatment sessions2 Model. Not actual patient. The Demand Is Clear Not only does AviClear meet the demand for the #1 dermatologic condition in the US, but it’s also a long-term, durable solution for mild,...

 Open the catalog to page 2
AviClear product brochure-3

Results that Redefine What’s Possible Photos courtesy of Southface Dermatology Photos courtesy of Medizen 1 MONTH AFTER 3 TREATMENTS Photos courtesy of Vein Care Center 12 MONTHS AFTER 3 TREATMENTS Photos courtesy of Anjali Mahto, MD Photos courtesy of Deep Blue Med Spa Photos courtesy of Loretta Zanetti, ARNP Individual results may vary. Patients should talk to their healthcare provider.

 Open the catalog to page 3
AviClear product brochure-4

The Results Are Clear The pivotal study for AviClear was an open-label study of 104 patients of any skin type and with mild, moderate, or severe inflammatory acne vulgaris. Treatment Success (Primary Endpoint) 12 MONTHS AFTER FINAL TREATMENT SESSION AGE: 23 | SKIN TYPE: IV Improved from Moderate to Almost Clear CLEAR OR ALMOST CLEAR 66% INFLAMMATORY LESION REDUCTION PERCENT REDUCTION IN INFLAMMATORY ACNE LESIONS AGE: 18 | SKIN TYPE: IV Improved from Severe to Clear 12 MONTHS AFTER FINAL TREATMENT SESSION AGE: 18 | SKIN TYPE: V Improved from Moderate to Clear 12 MONTHS AFTER FINAL TREATMENT SESSION...

 Open the catalog to page 4
AviClear product brochure-5

Treat Acne at the Source Research indicates that at 1726 nm, pure sebum absorbs approximately 2x more energy compared to H2O.7 AviClear selectively delivers energy to damage the sebocytes and suppress sebum production without compromising the epidermis.4 The proven 1726 nm wavelength selectively delivers energy to the sebaceous gland. The heat damages the sebocytes and suppresses sebum production, while other chromophores and the epidermis remain intact. AviClear is designed with the exclusive AviCool technology. The combination of sapphire contact cooling and smart sensors provides a safe and...

 Open the catalog to page 5
AviClear product brochure-6

Become a provider today.Scan for more information. www.aviclear.com References: 1. Data on file. AviClear pivotal study. Cutera, Inc. 2. Data on file. Cutera, Inc. 3. American Academy of Dermatology. Skin conditions by the numbers. Available at https://www.aad.org/media/stats-numbers#:~:text=Acne%20is%20the%20 most%20common,to%2050%20million%20Americans%20annuaiTy.&text=Acne%20usually%20beqins%20in%20puberty%20 and%20affects%20many%20adolescents%20and%20young%20adults. Last accessed February 27, 2024. 4. Goldberg D, et al. Selective photothermolysis with a novel 1726 nm laser beam: A safe and...

 Open the catalog to page 6

All Cutera catalogs and technical brochures

*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.
About MedicalExpo
MedicalExpo is a marketplace that offers B2B players a complete experience, from product sourcing to purchase. MedicalExpo is an entity of VirtualExpo Group.